Top Quality Pharmaceutical Powder Raloxifene Hydrochloride CAS: 82640-04-8
- Manufacturer: Dewael
- Product Assay: 99%+
- Appearance:light yellow powder
- Place of Origin: China
- Certification: SGS,ISO9001,GMP
- Minimum Order Quantity: 10g
- Packaging Details: 1 kg/foil bag,25kg/drum or as your requirements
- Delivery Time: Within 12 hours after receiving your payment
- Payment Terms: Western Union, MoneyGram,Bitcoin,Bank Transfer
- Shipping: EMS,DHL,Fedex,UPS,TNT and so on.
- Policy: Re-Shipping Policy
- Supply ability: 500-600kg/month
Top Quality Pharmaceutical Powder Raloxifene Hydrochloride CAS: 82640-04-8
Details:
Name:raloxifene hcl, Raloxifene hydrochloride
CAS No.:82640-04-8
MF:C28H28ClNO4S
Use:antineoplastic
Appearance:light yellow powder
Specification:
| Product Name: | Raloxifene hydrochloride |
| CAS: | 82640-04-8 |
| MF: | C28H28ClNO4S |
| MW: | 510.04 |
| Product Categories: | Active Pharmaceutical Ingredients;Raloxifene;Intracellular receptor;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Pharmaceutical intermediate |
| Mol File: | 82640-04-8.mol |
| mp | 250-253°C |
| storage temp. | -20°C Freezer |
| solubility | DMSO: 28 mg/mL, soluble |
| form | solid |
| color | light yellow |
| CAS DataBase Reference | 82640-04-8(CAS DataBase Reference) |
| Chemical Properties | Light-Yellow Solid |
| Usage | A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic. |
Raloxifene Hydrochloride Description:
Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.
Raloxifene Hydrochloride Application:
Because of Raloxifene’s greater differences in its selectivity of Estrogen agonism and antagonism in different tissues in the body, there is ongoing investigation of its application in other diseases, including prostate cancer, acromegaly, uterine cancer, cardiovascular disease, and breast cancer.
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate.
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.
———————————————————————————————————————————————————————————————————————————————————————-
Contact Now
Reviews
There are no reviews yet.